Research location
Carmel
Indiana, United States
Advertisement
Research activity in Carmel
Indiana, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 119 trials and 120 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Carmel
119 linked trials · page 1 of 3Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialNCT07391774 · 2026-08-10 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabNCT06876714 · 2025-09-17 · 1 site observation
RECRUITING
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialNCT06498635 · 2025-04-01 · 1 site observation
RECRUITING
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderNCT06830044 · 2025-03-03 · 1 site observation
RECRUITING
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast CancersNCT05846789 · 2024-07-02 · 1 site observation
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
ASCVD Management Using CCTA in Prostate Cancer Patients on ADTNCT05879913 · 2023-12-15 · 1 site observation
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25NCT05879926 · 2023-10-18 · 1 site observation
RECRUITING
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TNCT06134232 · 2023-10-02 · 1 site observation
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerNCT05929768 · 2023-09-15 · 1 site observation
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabNCT05812807 · 2023-06-14 · 1 site observation
RECRUITING
Exercise in Metastatic Breast Cancer: EMBodyNCT05468034 · 2023-04-26 · 1 site observation
RECRUITING
Biomarker of Diabetic RetinopathyNCT05079399 · 2022-01-01 · 1 site observation
RECRUITING
RA-PRO PRAGMATIC TRIALNCT04692493 · 2021-09-22 · 1 site observation
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)NCT04852887 · 2021-06-23 · 1 site observation
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs THNCT04893109 · 2021-06-16 · 2 site observations
RECRUITING
Safety and Efficacy of OTL78 (Zopocianine)NCT07725523 · 2026-10-01 · 1 site observation
NOT_YET_RECRUITING
Pilot Randomized Clinical Trial of Informational Support Versus Spiritual CareNCT07176559 · 2025-09-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 InjectionNCT06849544 · 2025-04-02 · 1 site observation
COMPLETED
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19 · 1 site observation
SUSPENDED
Description of Patients With Type 1 Diabetes Treated With TeplizumabNCT06892002 · 2025-02-11 · 1 site observation
COMPLETED
CYTALUX™for the Intraoperative Imaging of Prostate CancerNCT06434909 · 2024-09-19 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)NCT06270836 · 2024-05-01 · 1 site observation
COMPLETED
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerNCT06235151 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerNCT06235099 · 2024-04-01 · 1 site observation
COMPLETED
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsNCT05896189 · 2024-02-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)NCT06011798 · 2023-08-23 · 1 site observation
COMPLETED
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateNCT05605964 · 2023-01-28 · 1 site observation
COMPLETED
Phase 2b Study of ALTO-100 in MDDNCT05712187 · 2023-01-10 · 1 site observation
COMPLETED
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXNCT05467176 · 2022-10-04 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)NCT05335122 · 2022-03-16 · 1 site observation
COMPLETED
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)NCT05103358 · 2022-03-10 · 1 site observation
COMPLETED
Breast Cancer BRCA1 Carriers: a Pilot StudyNCT05062174 · 2021-11-01 · 1 site observation
WITHDRAWN
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)NCT04930055 · 2021-06-30 · 1 site observation
TERMINATED
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityNCT04804644 · 2021-06-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Tivanisiran for Dry Eye in Subjects With Sjögren's SyndromeNCT04819269 · 2021-05-25 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of APX3330 in Diabetic RetinopathyNCT04692688 · 2021-04-08 · 1 site observation
COMPLETED
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)NCT03460769 · 2021-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialNCT04457596 · 2021-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve ReplacementNCT04717570 · 2021-02-01 · 1 site observation
UNKNOWN
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialNCT04513717 · 2021-01-21 · 1 site observation
ACTIVE_NOT_RECRUITING
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionNCT04499248 · 2020-11-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)NCT04496739 · 2020-10-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseNCT04429503 · 2020-06-29 · 1 site observation
COMPLETED
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular IschemiaNCT04424290 · 2020-06-12 · 1 site observation
COMPLETED
NCI COVID-19 in Cancer Patients, NCCAPS StudyNCT04387656 · 2020-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung CancerNCT04155034 · 2020-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyNCT04266249 · 2020-03-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerNCT04001829 · 2019-08-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.